GoodRx Holdings (GDRX) Shares Outstanding (2019 - 2026)

GoodRx Holdings has disclosed Shares Outstanding (Entity) across 8 years of filings, most recently posting $340.1 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 3.58% year-over-year to $340.1 million; the TTM figure through Jun 2026 stood at $340.1 million (down 3.58% YoY), while the FY2025 annual figure was $341.1 million, down 10.91% from the prior year.
• Shares Outstanding (Entity) came in at $340.1 million for Q2 2026 at GoodRx Holdings, up from $337.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $398.4 million in Q3 2023 to a low of $337.6 million in Q1 2026.
• Average Shares Outstanding (Entity) over 5 years is $375.8 million, with a median of $381.8 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) increased 0.94% in 2022 and dropped 10.91% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $397.0 million in 2022, then dropped by 0.74% to $394.1 million in 2023, then decreased by 2.86% to $382.8 million in 2024, then fell by 10.91% to $341.1 million in 2025, then declined by 0.27% to $340.1 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $340.1 million in Q2 2026, $337.6 million in Q1 2026, and $341.1 million in Q4 2025.